Limits...
Lung tumour markers in oncology practice: a study of TPA and CA125.

Buccheri G, Ferrigno D - Br. J. Cancer (2002)

Bottom Line: Several substances mark the course of lung cancer and may reliably help the clinician in decision-making.Three hundred and eighty-four new lung cancer patients (309 males) were studied at their first clinical presentation and then strictly followed-up.The two marker tests are similarly helpful and appear complementary, given the low inter-marker correlation and their independent prognostic capability.

View Article: PubMed Central - PubMed

Affiliation: Divisione di Pneumologia, Ospedale S. Croce e Carle, I-12100 Cuneo, Italy. buccheri@culcasg.org

Show MeSH

Related in: MedlinePlus

Receiver-operating characteristic (ROC) curves showing the capability of CA125 to diagnose a cancerous pleural effusion (area under the curve: 0.748, 95% confidence interval: 0.695–0.801, P<0.001).
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2376192&req=5

fig2: Receiver-operating characteristic (ROC) curves showing the capability of CA125 to diagnose a cancerous pleural effusion (area under the curve: 0.748, 95% confidence interval: 0.695–0.801, P<0.001).

Mentions: Scatter-plot showing pre-treatment levels of CA125 and TPA, measured blindly of clinical information, in 384 new lung cancer patients (Spearman Rho Correlation Coefficient: 0.24).


Lung tumour markers in oncology practice: a study of TPA and CA125.

Buccheri G, Ferrigno D - Br. J. Cancer (2002)

Receiver-operating characteristic (ROC) curves showing the capability of CA125 to diagnose a cancerous pleural effusion (area under the curve: 0.748, 95% confidence interval: 0.695–0.801, P<0.001).
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2376192&req=5

fig2: Receiver-operating characteristic (ROC) curves showing the capability of CA125 to diagnose a cancerous pleural effusion (area under the curve: 0.748, 95% confidence interval: 0.695–0.801, P<0.001).
Mentions: Scatter-plot showing pre-treatment levels of CA125 and TPA, measured blindly of clinical information, in 384 new lung cancer patients (Spearman Rho Correlation Coefficient: 0.24).

Bottom Line: Several substances mark the course of lung cancer and may reliably help the clinician in decision-making.Three hundred and eighty-four new lung cancer patients (309 males) were studied at their first clinical presentation and then strictly followed-up.The two marker tests are similarly helpful and appear complementary, given the low inter-marker correlation and their independent prognostic capability.

View Article: PubMed Central - PubMed

Affiliation: Divisione di Pneumologia, Ospedale S. Croce e Carle, I-12100 Cuneo, Italy. buccheri@culcasg.org

Show MeSH
Related in: MedlinePlus